References
- Drug Abuse Screening Market. USA Market Potential Corporation, New York 1972
- Way E. B., Adler T. K. The biological disposition of morphine and its surrogates. Bull. World Health Org. 1961; 25: 227
- Oberst F. W. Free and bound morphine in the urine of morphine addicts. J. Pharmacol. Exptl. Therap. 1940; 69: 240
- Pohland A., Boaz H. E., Sullivan H. R. Synthesis and identification of metabolites resulting from the biotransformation of dl-methadone in man and in the rat. J. Med. Chem. 1971; 14: 194
- Sullivan H. R., Due S. L. Urinary metabolites of dl-methadone in maintenance subjects. J. Med. Chem. 1973; 16: 909
- McIntire J. A. Private communication
- Parker K. D., Elliott H. W., Wright J. A., Nomof N., Hine C. H. Blood and urine concentrations of subjects receiving barbiturates, meprobamate, glutethimide or diphenylhydantoin. Clin. Toxicol. 1970; 3(1)131
- Dring L. G., Smith R. L., Williams R. T. The metabolic fate of amphetamine in man and other species. Biochem. J. 1970; 116: 425
- Fish F., Wilson W. D. C. Excretion of cocaine and its metabolites in man. J. Pharm. Pharmacol. 1969; 21: 135s, Suppl.
- Bastos M. S., Jukofsky D., Mule S. J. Routine identification of cocaine metabolites in human urine. J. Chromatogr. 1974; 89: 335